184 related articles for article (PubMed ID: 23475163)
1. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results.
Krokidis M; Spiliopoulos S; Jarzabek M; Fotiadis N; Sabharwal T; O'Brien T; Adam A
Eur Radiol; 2013 Jul; 23(7):1933-9. PubMed ID: 23475163
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
3. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.
Balageas P; Cornelis F; Le Bras Y; Hubrecht R; Bernhard JC; Ferrière JM; Ravaud A; Grenier N
Eur Radiol; 2013 Jul; 23(7):1925-32. PubMed ID: 23443351
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
Ma Y; Bedir S; Cadeddu JA; Gahan JC
BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
10. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
12. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
14. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
Cool DW; Kachura JR
J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
18. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]